Found 49 results in Expert Content

Summary: Discover how Catalent, a specialized CDMO, accelerates time to market for inhalation innovators with end-to-end solutions.

Summary: In this article, experts discuss how the intranasal route offers advantages like faster absorption and minimal product degradation, but also the complex issues to consider when designing a device that will ensure the efficacy of a particular formulation.

Summary: This article, originally published in Inhalation Magazine, discusses process & applications considerations for the spray drying of inhaled powders, considerations for formulating biologics as respirable powders and inhalation for non-respiratory indications.

Summary: In this article experts shared their insights on developing intranasal products and scaling them for commercial supply.

Summary: In this article, Mark Ignaczak provides insight into the history of nasal drug delivery and the advantages of the nasal delivery route.

This webinar will discuss challenges and key considerations for spray-dried formulations for inhalation, along with a review of current technologies and approved products utilizing particle engineering approaches.

Summary: Learn more about developing intranasal products, advantages of intranasal vaccines & the considerations and challenges associated with this delivery route.

Summary: This executive summary explores the rationale for intranasal drug delivery and the key intranasal drug product formulation design and optimization considerations that can help ensure safe and effective product performance and manufacturability.​

Listen to this webinar to hear experts share insights into developing intranasal vaccine analytical tools, how to improve the speed and quality of critical batch release and characterization assays and the importance of device selection in determining product performance.

The aim of this study was to verify if the GastroPlus® PBPK software can be used to predict intranasal absorption by comparing predictions with human intranasal pharmacokinetic data from the literature.